Advertisement

Topics

Advertisement

Solid Tumors

Hematologic Malignancies

Issues in Oncology

Supportive Care

Advertisement

Advertisement

May

27

Today In Oncology

Continuous Coverage of COVID-19

ASCO Survey on Early Impact of COVID-19 on the Performance of Oncology Clinical Trials

Outcomes With Autologous-Allogeneic vs Tandem Autologous Hematopoietic Cell Transplantation in Patients With Newly Diagnosed Multiple Myeloma

Neoadjuvant Nivolumab for Resectable Merkel Cell Carcinoma

AI Model Accurately Classifies Colorectal Polyps From Histopathologic Slides

Advertisement

Most Read Stories

When Can Patients With Gleason 6 Prostate Cancer Safely Undergo Active Surveillance?

FDA Approves Atezolizumab for the First-Line Treatment of Patients With Metastatic NSCLC and High PD-L1 Expression

Lessons Learned on Rotation at COVID-19 Inpatient Service at New York City Hospital

New ASCO Guideline Addresses Head/Neck Squamous Cell Carcinoma of Unknown Primary

10 Changes I Will Make in My Oncology Practice as a Result of COVID-19

Most Viewed Videos

Francesca Battaglin, MD, on Colorectal Cancer: Using Genetic Variants to Predict Treatment Efficacy

Steven J. O’Day, MD, on Triple-Negative Breast Cancer: Clinical Benefit With Pembrolizumab Plus Imprime PGG

Susan Blumel, RN, BSN, and Laura J. Zitella, MS, RN, ACNP-BC, AOCN, on Managing Toxicities of Immunotherapy

Andrew X. Zhu, MD, PhD, on Hepatocellular Carcinoma: Atezolizumab Combined With Bevacizumab

Hope S. Rugo, MD, on Talazoparib for Advanced Solid Tumors: Reduced Hospitalization and Supportive Care

© 2020 HSP News Service, L.L.C.